The patient underwent a WES analysis for GDD and was found to harbor the novel heterozygous de novo pathogenic (PVS1, PM2, PP5) KMT5B(NM_017635.5): c.559C > T; (p.Arg187Ter) variant. Here, KMT5B is linked to Global developmental delay.